| 发明名称 |
Treatment of diabetes |
| 摘要 |
The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
|
| 申请公布号 |
EP1779851(A1) |
申请公布日期 |
2007.05.02 |
| 申请号 |
EP20050023794 |
申请日期 |
2005.10.31 |
| 申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
发明人 |
DUGI, KLAUS;BERGER, FRANK;RASCHIG, ANDREAS;REESS, JUERGEN;SALIN, LAURENCE |
| 分类号 |
A61K31/46;A61K45/06;A61P5/50 |
主分类号 |
A61K31/46 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
